Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Asset Writedowns and Impairment: 2009-2024

Historic Asset Writedowns and Impairment for Cross Country Healthcare (CCRN) over the last 15 years, with FY2024 value amounting to $21.4 million.

  • Cross Country Healthcare's Asset Writedowns and Impairment fell 15694.44% to -$861000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$766000.0, marking a year-over-year decrease of 10189.05%. This contributed to the annual value of $21.4 million for FY2024, which is 4717.76% up from last year.
  • Latest data reveals that Cross Country Healthcare reported Asset Writedowns and Impairment of $21.4 million as of FY2024, which was up 4717.76% from $14.6 million recorded in FY2023.
  • In the past 5 years, Cross Country Healthcare's Asset Writedowns and Impairment ranged from a high of $21.4 million in FY2024 and a low of $4.8 million during FY2021
  • For the 5-year period, Cross Country Healthcare's Asset Writedowns and Impairment averaged around $13.3 million, with its median value being $14.6 million (2023).
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first crashed by 7056.25% in 2021, then skyrocketed by 10089.9% in 2022.
  • Annual analysis of 5 years shows Cross Country Healthcare's Asset Writedowns and Impairment stood at $16.2 million in 2020, then crashed by 70.56% to $4.8 million in 2021, then skyrocketed by 100.9% to $9.6 million in 2022, then skyrocketed by 51.55% to $14.6 million in 2023, then surged by 47.18% to $21.4 million in 2024.
  • Its last three reported values are $21.4 million in FY2024, $14.6 million for FY2023, and $9.6 million during FY2022.